Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tara L PetersJonathan H Schatz

Abstract

Purpose: The DEAD-box RNA helicase eIF4A1 carries out the key enzymatic step of cap-dependent translation initiation and is a well-established target for cancer therapy, but no drug against it has entered evaluation in patients. We identified and characterized a natural compound with broad antitumor activities that emerged from the first target-based screen to identify novel eIF4A1 inhibitors.Experimental Design: We tested potency and specificity of the marine compound elatol versus eIF4A1 ATPase activity. We also assessed eIF4A1 helicase inhibition, binding between the compound and the target including binding site mutagenesis, and extensive mechanistic studies in cells. Finally, we determined maximum tolerated dosing in vivo and assessed activity against xenografted tumors.Results: We found elatol is a specific inhibitor of ATP hydrolysis by eIF4A1 in vitro with broad activity against multiple tumor types. The compound inhibits eIF4A1 helicase activity and binds the target with unexpected 2:1 stoichiometry at key sites in its helicase core. Sensitive tumor cells suffer acute loss of translationally regulated proteins, leading to growth arrest and apoptosis. In contrast to other eIF4A1 inhibitors, elatol induces markers of an ...Continue Reading

References

Jan 20, 2004·RNA·Chia C ChanGideon Dreyfuss
Feb 11, 2004·Nucleic Acids Research·Olivia NovacJerry Pelletier
Jul 28, 2004·Proceedings of the National Academy of Sciences of the United States of America·Krishna M Vattem, Ronald C Wek
Sep 20, 2005·Nature Structural & Molecular Biology·Lionel BallutHervé Le Hir
Mar 15, 2006·Nature Chemical Biology·Marie-Eve BordeleauJerry Pelletier
Dec 23, 2006·Chemistry & Biology·Marie-Eve BordeleauJerry Pelletier
Jun 14, 2008·The Journal of Clinical Investigation·Marie-Eve BordeleauJerry Pelletier
May 20, 2011·Nature·Björn SchwanhäusserMatthias Selbach
Aug 24, 2011·The Journal of Experimental Medicine·Jonathan H SchatzHans-Guido Wendel
May 17, 2012·RNA·Gabriela Galicia-VázquezJerry Pelletier
Jul 11, 2012·The Journal of Pharmacy and Pharmacology·Andreza CamposJarbas Mota Siqueira
Sep 22, 2012·RNA Biology·Alexandra Z Andreou, Dagmar Klostermeier
Sep 28, 2012·Marine Drugs·Vânia Cristina DesotiSueli de Oliveira Silva
Feb 7, 2014·Annual Review of Biochemistry·Alan G Hinnebusch
Feb 7, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Varsha GandhiJorge E Cortes
Aug 1, 2014·Nature·Andrew L WolfeHans-Guido Wendel
Aug 1, 2014·Nature·Lise BoussemartStéphan Vagner
Mar 7, 2015·Nature Reviews. Drug Discovery·Mamatha BhatIvan Topisirovic
Mar 15, 2015·Nucleic Acids Research·Oscar MendozaJean-Louis Mergny
Aug 20, 2015·RNA·Gabriela Galicia-VázquezJerry Pelletier
Dec 17, 2015·Molecular and Cellular Biology·Christopher J HugginsPeter F Johnson
Jul 19, 2016·Trends in Cell Biology·Jennifer ChuJerry Pelletier
Sep 16, 2016·EMBO Reports·Karolina Pakos-ZebruckaAdrienne M Gorman
Aug 2, 2017·Bioorganic & Medicinal Chemistry Letters·Joseph TillotsonEli Chapman
Feb 22, 2018·Oncogene·Santiago Ramon Y CajalNahum Sonenberg

❮ Previous
Next ❯

Citations

Jan 10, 2019·Marine Drugs·Giuseppe ErcolanoAngela Ianaro
Jan 15, 2020·Current Medicinal Chemistry·Dario MatuljaDean Marković
Feb 6, 2020·RNA·Sai Kiran NaineniJerry Pelletier
Nov 27, 2018·Oncotarget·Tyler A CunninghamJonathan H Schatz
May 28, 2020·Cancers·Stefanie SchmidtArmin Wiegering
May 7, 2020·Frontiers in Chemistry·Nihay Laham-KaramPiia Kokkonen
Sep 15, 2020·Exploration of Targeted Anti-tumor Therapy·Joe TaylorGraham Packham
Jul 17, 2020·Frontiers in Cell and Developmental Biology·Yixuan ZhaoQingfeng Li
Jan 1, 2021·The FEBS Journal·Emma Minnee, William James Faller
Nov 6, 2020·Cell Communication and Signaling : CCS·Peiqi HaoTianrui Xu
Nov 20, 2020·Antibiotics·Chukwuemeka Samson AhamefuleWenxia Fang
Oct 23, 2021·Journal of Medicinal Chemistry·Christopher J ZerioEli Chapman
Nov 6, 2021·Scientific Reports·Thanh-Trang VoDavid A Fruman
Dec 7, 2021·Frontiers in Cell and Developmental Biology·Chen XueLanjuan Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.